cedar.comHealthcare / Healthcare softwareFounded: 2016Funding to Date: $389.1MM
Cedar’s mission is to make healthcare more affordable and accessible through our consumer-friendly platform that’s powered by data science, smart product design and personalization. Cedar’s enterprise platform reduces administrative and billing friction, leading to better outcomes for providers, payers and the people they serve. This company was founded by Arel Lidow, Florian Otto, and Kareem Zaki in 2016 and is headquartered in New York, NY.
Funding Date | Share Class | Amount Raised | Price per Share | Post-Money Valuation | Key Investors | |
---|---|---|---|---|---|---|
12/19/2022 | Series D | $255MM | $xx.xx | $3.19B | Tiger Global Management, Andreessen Horowitz, Thrive Capital, Concord Health Partners, Memorial Hermann Health System | |
Price per Share
$xx.xx
Shares Outstanding
1,060,175
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Tiger Global Management, Andreessen Horowitz, Thrive Capital, Concord Health Partners, Memorial Hermann Health System
|
||||||
06/22/2020 | Series C | $79.8MM | $xx.xx | $814.72MM | Andreessen Horowitz, JP Morgan | |
Price per Share
$xx.xx
Shares Outstanding
1,335,516
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Andreessen Horowitz, JP Morgan
|
||||||
06/25/2018 | Series B | $41.3MM | $xx.xx | $286.28MM | Kinnevik, Founders Fund, Thrive Capital, Lakestar, Sound Ventures, Kevin Systrom, Nat Turner | |
Price per Share
$xx.xx
Shares Outstanding
1,978,507
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Kinnevik, Founders Fund, Thrive Capital, Lakestar, Sound Ventures, Kevin Systrom, Nat Turner
|
||||||
12/06/2017 | Series A-1 | $3MM | $xx.xx | $73.6MM | Founders Fund, Martin Ventures, SV Angel, Thrive Capital | |
Price per Share
$xx.xx
Shares Outstanding
1,288,214
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Founders Fund, Martin Ventures, SV Angel, Thrive Capital
|
||||||
12/06/2017 | Series A | $10MM | $xx.xx | $73.6MM | Founders Fund, Martin Ventures, SV Angel, Thrive Capital | |
Price per Share
$xx.xx
Shares Outstanding
1,533,567
Liquidation Pref Order
1
Liquidation Pref As Multiplier
1.0x
Conversion Ratio
1.0x
Dividend Rate
8.0%
Cumulative
Non-cumulative
Participating
Non-participating
Participation Cap
N/A
Key Investors
Founders Fund, Martin Ventures, SV Angel, Thrive Capital
|